Free Trial

Pulse Biosciences (PLSE) Scheduled to Post Earnings on Wednesday

Pulse Biosciences logo with Medical background

Pulse Biosciences (NASDAQ:PLSE - Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, October 30th. Persons interested in participating in the company's earnings conference call can do so using this link.

Pulse Biosciences Price Performance

Shares of PLSE stock traded down $0.79 during trading hours on Wednesday, reaching $16.84. 123,456 shares of the stock were exchanged, compared to its average volume of 202,746. The business's fifty day moving average is $17.93 and its two-hundred day moving average is $13.86. Pulse Biosciences has a 12-month low of $3.78 and a 12-month high of $22.69. The firm has a market capitalization of $1.03 billion, a P/E ratio of -20.79 and a beta of 1.74.

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of Pulse Biosciences to a "sell" rating in a research note on Friday, September 20th.

Check Out Our Latest Stock Analysis on Pulse Biosciences

Pulse Biosciences Company Profile

(Get Free Report)

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.

See Also

Earnings History for Pulse Biosciences (NASDAQ:PLSE)

Should you invest $1,000 in Pulse Biosciences right now?

Before you consider Pulse Biosciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pulse Biosciences wasn't on the list.

While Pulse Biosciences currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines